Drug Discovery World

FEBRUARY 10, 2023

For life sciences companies across Sweden and the Nordics in general, generating funding equal to international partners in places like the US has proven difficult. He is now a founding partner of EIR Ventures, a venture capital firm investing in innovative companies across the Nordics. “We

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

Advarra

JULY 19, 2022

Q: If an emergency use authorization (EUA) is granted, once there is an approved treatment, does that mean that the EUA is no longer valid? The sponsor is the pharmaceutical company conducting the trial. A: Working in a pharmaceutical company is the best way to learn this. A: Yes, the EUA is just temporary.

Packaging 52

Packaging FDA Regulations Trials 52

Drug Discovery World

MAY 7, 2024

Add to this that the rise of AMR can bring about what the report calls a return to the ‘dark age of medicine’ where surgeries, cancer treatments, even childbirths, become staggeringly more dangerous when there is a lack of effective antibiotics, and it’s easy to understand why there’s such reason for concern.

Vaccine 147

Vaccine Pharmaceutical Companies Clinical Trials Trials 147

DrugBank

JUNE 27, 2024

Add to that, these drugs have already passed safety tests, meaning they could potentially move through early-phase trials faster if doses are compatible for new uses. These include matching molecular signatures, virtual screening, and analyzing large datasets from health records and clinical trials.

Drugs 71

Drugs Pharma Companies Computational Chemistry Clinical Trials 71

Drug Discovery World

JANUARY 26, 2023

Research into HIV blossomed throughout 2022, with ViiV Healthcare’s combination therapy for HIV-1 gaining approval in Japan; and research moving forward towards a one-time treatment for HIV as well as a vaccine. As such, 2022 saw a marked fall in ROI for global pharmaceutical companies and their research and development activities.

Clinical Trials 246

Clinical Trials Drugs Trials Therapies 246

Drug Discovery World

JANUARY 5, 2023

There is a real danger for companies simply reacting to the latest EMA mandates, such as the specifics of how data will look under the EU’s eventual implementation of Identification of Medicinal Products (IDMP), and the perceived ‘watering down’ of data-driven process requirements via the shift to Digital Application Dataset Integration (DADI).

Pharma Companies 130

Pharma Companies International Compliance Production 130

The Open Targets Blog

OCTOBER 24, 2023

OMass Therapeutics is using a new technology platform to develop treatments for rare immunological and genetic diseases with high unmet patient needs. Although pharma companies can be competitive, this kind of tool will not generate any IP, and it saved us so much work that we knew it could be of real benefit to the community.

Bioinformatics 64

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 64

Drug Discovery World

AUGUST 16, 2022

These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . used in patient intake forms can influence clinical decisions or treatment protocols.

Research 130

Research Clinical Trials Trials Drug Development 130

Codon

FEBRUARY 13, 2024

doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.

Therapies 118

Therapies Virus DNA Clinical Trials 118

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. What is a value-added medicine?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Production 52

Drug Discovery World

SEPTEMBER 7, 2022

The drug discovery and development process is costly and arduous, offering no certainty of success which often rests on whether a company has chosen the correct drug molecule and target. BenevolentAI was able to witness this level of fast-tracked development when it used its platform to help discover a potential Covid-19 treatment.

Research 130

Research Clinical Trials Pharmaceutical Companies Pharma Companies 130

The Pharma Data

OCTOBER 14, 2020

AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. Food and Drug Administration granted Breakthrough Therapy designation to France-based Inventiva’s experimental NASH treatment lanifibranor. adults age 65 and older.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Pharmaceutical Companies 52

The Pharma Data

DECEMBER 30, 2020

In September 2020, the trials were halted to investigate a potentially severe side effect in a UK patient, transverse myelitis, an inflammation of part of the spinal cord. After a short break, the trial restarted in the UK and other parts of the world, but was delayed for much longer in the U.S. M&A.

Vaccine 52

Vaccine FDA Trials Therapies 52